Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

July 2025; Volume 45,Issue 7

Special Issue on New Anticancer Agents

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, NAOKO

    1. You have access
      Ketone Bodies Inhibit Growth of Hepatoblastoma and Rhabdoid Tumor of the Kidney Cells
      ERI MUTO-FUJITA, BIN YAMAOKA, NAOKO ABE, KYOKO FUJIWARA and SHUICHIRO UEHARA
      Anticancer Research July 2025, 45 (7) 3089-3097; DOI: https://doi.org/10.21873/anticanres.17673
  2. Adachi, NOBUO

    1. You have access
      High Antitumor Effects and Reduced Side Effects of Doxorubicin Prodrug Active Only Under Hypoxic Conditions
      KOKI YOSHIOKA, TAISUKE FURUTA, TOMOHIKO SAKUDA, AKIHIRO ODA, YUTAKA IKEDA, SHIGERU MIYAKI, YUKIO NAGASAKI and NOBUO ADACHI
      Anticancer Research July 2025, 45 (7) 2905-2916; DOI: https://doi.org/10.21873/anticanres.17658
  3. Aida, RIEKO

    1. Open Access
      Apigenin-induced Apoptosis in Lung Adenocarcinoma A549 Cells: Involvement in IFNA2, TNF, and SPON2 With Different Time Points
      RIEKO AIDA, KAZUNORI OKANO, KYOKO NAKATA and HIROMI HAGIWARA
      Anticancer Research July 2025, 45 (7) 2781-2790; DOI: https://doi.org/10.21873/anticanres.17647
  4. Alban, SUSANNE

    1. Open Access
      Fucoidan Treatment Leads to Attenuated Growth Factor Signaling and Reduced Proliferation in Neuroblastoma Cells
      NIKLAS WEBER, NINA SOPHIE POMMERT, MEIKE KAEHLER, INGOLF CASCORBI, SUSANNE ALBAN and VICKI WAETZIG
      Anticancer Research July 2025, 45 (7) 2749-2762; DOI: https://doi.org/10.21873/anticanres.17644
  5. Albino, VITTORIO

    1. Open Access
      Cannabinoids as Potential Therapeutic Agents in the Treatment of Pancreatic Cancer
      SABRINA BIMONTE, DAVIDE NOCERINO, MARCO CRISCI, DANIELA SCHIAVO, VITTORIO ALBINO, MAURIZIO MARCHESINI and ARTURO CUOMO
      Anticancer Research July 2025, 45 (7) 2719-2728; DOI: https://doi.org/10.21873/anticanres.17642
  6. Alkhayyal, NOURA

    1. Open Access
      Unlocking New Frontiers in Breast Cancer: The Role of the Tumor Microenvironment, Cutting-Edge Therapies, and Immunotherapy
      DOUA KAMYAN, NOHA M. ELEMAM, NOURA ALKHAYYAL, IMAN M. TALAAT and RIYAD BENDARDAF
      Anticancer Research July 2025, 45 (7) 2729-2747; DOI: https://doi.org/10.21873/anticanres.17643
  7. Amore, ALFONSO

    1. Open Access
      Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
      ANNA CRISPO, ASSUNTA LUONGO, DAVIDE NOCERINO, MARCO CASCELLA, MARCO CRISCI, FRANCESCA BIFULCO, DANIELA SCHIAVO, MAURIZIO MARCHESINI, SERGIO COLUCCIA, MELANIA PRETE, ALFONSO AMORE, EGIDIO CELENTANO, SABRINA BIMONTE and ARTURO CUOMO
      Anticancer Research July 2025, 45 (7) 3149-3164; DOI: https://doi.org/10.21873/anticanres.17678
  8. An, SUHYEON

    1. You have access
      Integrating Network Pharmacology and Optimization of Preparation Methods to Enhance the Anticancer Effect of Cordyceps militaris on Lung Cancer
      HYE-LIN KIM, JUNKYU PARK, HYO IN KIM, MINA BOO, JAE HEON SIM, HARIM KIM, HYUNYOUNG CHOI, SUHYEON AN, HYUNSOO YANG, SUJIN SHIN, YOHAN HAN, HYOJEONG KIM, JINBONG PARK and KYUNGJIN LEE
      Anticancer Research July 2025, 45 (7) 2963-2984; DOI: https://doi.org/10.21873/anticanres.17663
  9. Appelman-dijkstra, NATASHA M.

    1. Open Access
      Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
      MARK T.J. VAN BUSSEL, NATHALIE BRAVENBOER, HUIB VAN ESSEN, PETUR SNAEBJORNSSON, NATASHA M. APPELMAN-DIJKSTRA, JAN HM SCHELLENS and FRANS L. OPDAM
      Anticancer Research July 2025, 45 (7) 3137-3147; DOI: https://doi.org/10.21873/anticanres.17677
  10. Ariizumi, TAKASHI

    1. You have access
      Heterogeneous c-Met Activation in Osteosarcoma Dictates Synergistic Vulnerability to Combined c-Met Inhibition and Methotrexate Therapy
      GUIDONG LI, HIROYUKI KAWASHIMA, TARO SASAKI, TAKASHI ARIIZUMI, NAOKI OIKE and AKIRA OGOSE
      Anticancer Research July 2025, 45 (7) 2791-2806; DOI: https://doi.org/10.21873/anticanres.17648
« Previous (Pages : 1 2 3 4 5 6 ... 25) Next »
Back to top
Previous

In this issue

Anticancer Research: 45 (7)
Anticancer Research
Vol. 45, Issue 7
July 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Cancer Stem Cells in Glioblastoma: The Role of the mTOR Pathway
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
  • Immunotherapy and Chemotherapy for Advanced or Recurrent Endometrial Carcinoma
  • Fucoidan Treatment Leads to Attenuated Growth Factor Signaling and Reduced Proliferation in Neuroblastoma Cells
  • The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire